Viking Global Investors LP Adaptive Biotechnologies Corp Transaction History
Viking Global Investors LP
- $29.6 Billion
- Q4 2024
A detailed history of Viking Global Investors LP transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Viking Global Investors LP holds 29,993,708 shares of ADPT stock, worth $250 Million. This represents 0.61% of its overall portfolio holdings.
Number of Shares
29,993,708
Previous 29,993,708
-0.0%
Holding current value
$250 Million
Previous $154 Million
17.19%
% of portfolio
0.61%
Previous 0.59%
Shares
3 transactions
Others Institutions Holding ADPT
# of Institutions
225Shares Held
146MCall Options Held
19.6KPut Options Held
27.2K-
Rubric Capital Management LP New York, NY14.6MShares$122 Million1.45% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$97.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$89.3 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.42MShares$78.5 Million0.49% of portfolio
-
Nikko Asset Management Americas, Inc.6.83MShares$56.9 Million0.46% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.19B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...